99 related articles for article (PubMed ID: 12591008)
21. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
22. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
23. Platelet activation is increased in cyclosporin A-induced hypertensive rats.
Reis F; Tavares P; Rito LC; Teixeira HM; Santos Dias JD; Ferrer-Antunes C; Mesquita JF; Teixeira F
J Cardiovasc Pharmacol; 2000 Jul; 36(1):56-64. PubMed ID: 10892661
[TBL] [Abstract][Full Text] [Related]
24. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.
Nishiyama A; Kobori H; Fukui T; Zhang GX; Yao L; Rahman M; Hitomi H; Kiyomoto H; Shokoji T; Kimura S; Kohno M; Abe Y
Hypertension; 2003 Oct; 42(4):754-60. PubMed ID: 12874088
[TBL] [Abstract][Full Text] [Related]
25. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
26. Different effects of the beta-adrenoceptor antagonists celiprolol and metoprolol on vascular structure and function in long-term type I diabetic rats.
Olbrich A; Salameh A; Roesen P; Dhein S
J Cardiovasc Pharmacol; 1999 Feb; 33(2):193-203. PubMed ID: 10028926
[TBL] [Abstract][Full Text] [Related]
27. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats.
Capasso G; Di Gennaro CI; Della Ragione F; Manna C; Ciarcia R; Florio S; Perna A; Pollastro RM; Damiano S; Mazzoni O; Galletti P; Zappia V
Nephrol Dial Transplant; 2008 Apr; 23(4):1186-95. PubMed ID: 18057067
[TBL] [Abstract][Full Text] [Related]
28. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.
Gardner MP; Houghton DC; Andoh TF; Lindsley J; Bennett WM
Transplantation; 1996 May; 61(10):1506-12. PubMed ID: 8633380
[TBL] [Abstract][Full Text] [Related]
29. Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
Torras J; Valles J; Sanchez J; Sabate I; Seron D; Carrera M; Castelao AM; Herrero I; Puig-Parellada P; Alsina J
Nephron; 1994; 67(1):66-72. PubMed ID: 8052370
[TBL] [Abstract][Full Text] [Related]
30. The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
Sodam BR; Awumey EM; Sampson WH; Epstein S
Calcif Tissue Int; 2001 Feb; 68(2):117-21. PubMed ID: 11310347
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine A-induced contractions and prostacyclin release are maintained by extracellular calcium in rat aortic rings: role of protein kinase C.
Oriji GK; Keiser HR
Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):151-6. PubMed ID: 9051725
[TBL] [Abstract][Full Text] [Related]
32. Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells: The Role of HSP70 Expression.
Rizos IK; Tsoporis JN; Toumpoulis IK; Salpeas V; Izhar S; Rigopoulos AG; Sakadakis EA; Parker TG
J Cardiovasc Pharmacol; 2018 Aug; 72(2):86-96. PubMed ID: 29738368
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Andoh TF; Gardner MP; Bennett WM
Transplantation; 1997 Nov; 64(9):1236-40. PubMed ID: 9371662
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
[TBL] [Abstract][Full Text] [Related]
35. Does methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment?
Rezzani R; Rodella L; Corsetti G; Bianchi R
Nephron; 2001 Nov; 89(3):329-36. PubMed ID: 11598398
[TBL] [Abstract][Full Text] [Related]
36. Sepsis alters vessel contraction by adrenoceptor-induced nitric oxide and prostanoid.
Kawabe T; Harris PD; Zakaria EL; Garrison RN
J Surg Res; 2003 Apr; 110(2):352-9. PubMed ID: 12788665
[TBL] [Abstract][Full Text] [Related]
37. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release.
Choi YS; Jeong YS; Ok SH; Shin IW; Lee SH; Park JY; Hwang EM; Hah YS; Sohn JT
Anesth Analg; 2010 Feb; 110(2):341-9. PubMed ID: 19955508
[TBL] [Abstract][Full Text] [Related]
38. Endothelium-dependent relaxation in the isolated rat kidney: impairment by cyclosporine A.
Stephan D; Billing A; Krieger JP; Grima M; Fabre M; Hofner M; Imbs JL; Barthelmebs M
J Cardiovasc Pharmacol; 1995 Dec; 26(6):859-68. PubMed ID: 8606521
[TBL] [Abstract][Full Text] [Related]
39. Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
Kim YJ; Park YH; Moon HK
Kidney Blood Press Res; 1997; 20(1):38-43. PubMed ID: 9192909
[TBL] [Abstract][Full Text] [Related]
40. Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine.
Chander V; Chopra K
Ren Fail; 2005; 27(4):441-50. PubMed ID: 16060134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
